EUVIMEDEUVIMED entdecken
Crossref

Silicon Nanoneedle Patches for Painless, Sustained Treatment of Macular Degeneration

Van Phuc Nguyen iD, Jinheon Jeong, Josh Zhe, Mi Zheng, Junsang Lee, Khoi Tran, Zhuying Wei, Chi Hwan Lee iD, Yannis M Paulus iD

ACS Biomaterials Science & Engineering · 2026

DOI: 10.1021/acsbiomaterials.5c01783 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Van Phuc Nguyen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland 21287, United States. Hauptthemen laut MEDLINE: Silicon, Macular Degeneration, Bevacizumab, Angiogenesis Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: NEI NIH HHS, International Retinal Research Foundation, National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Choroidal neovascularization (CNV) represents a major cause of vision loss in various retinal diseases such as age-related macular degeneration (AMD). Current treatment involves frequent, often monthly, eye injections. The development of minimally invasive, long-term, painless, and effective ocular drug delivery systems is crucial for advancing the treatment of AMD. This study explores a novel method that integrates controllably bioresorbable silicon nanoneedles loaded with bevacizumab (Si NNs-Bev) on a tear-soluble subconjunctival patch for sustained, 1 year ocular drug delivery. The Si NNs-Bev embed into the sclera in a minimally invasive manner, undergoing controlled degradation over one year. This approach facilitates the sustained release of therapeutic agents, enhancing treatment efficacy and reducing treatment burden. Si NNs-Bev for the treatment of CNV are validated in a rabbit model of AMD. The SiNN-Bev patch achieved a sustained therapeutic effect on CNV regression, with a mean reduction of 82% by 4 months that is persistent for at least 1 year with minimal recurrence, which is consistent with the localized drug delivery mechanism facilitated by the transscleral microneedles. These preliminary findings underscore the potential of SiNNs as a platform technology for long-term, sustained ocular therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SiliconMacular DegenerationBevacizumabAngiogenesis InhibitorsAnimalsRabbitsChoroidal NeovascularizationMicroneedle Drug DeliveryDrug Delivery Systems

Stichwörter der Autor:innen

age-related macular degenerationanti-VEGFbioresorbable silicon nanoneedlesocular drug delivery systemoptical coherence tomographyphotoacoustic microscopy

Substanzen

SiliconBevacizumabAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland 21287, United States.
  • Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan 48105, United States.
  • Weldon School of Biomedical Engineering, Purdue University, West Lafayette, Indiana 47907, United States.
  • Ophthalmology Department, Fujian Provincial Hospital, Fuzhou, Fujian 350001, China.
  • Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • School of Mechanical Engineering, Purdue University, West Lafayette, Indiana 47907, United States.

ORCID-Profile: Van Phuc Nguyen, Chi Hwan Lee, Yannis M Paulus

Förderung

  • NEI NIH HHS
  • International Retinal Research Foundation
  • National Eye Institute
  • Alcon Research Institute
  • Ministry of Trade, Industry and Energy
  • Johns Hopkins University
  • Korea Institute for Advancement of Technology

Zitieren

APA

Nguyen, V. P., Jeong, J., Zhe, J., Zheng, M., Lee, J., Tran, K., Wei, Z., Lee, C. H., & Paulus, Y. M. (2026). Silicon Nanoneedle Patches for Painless, Sustained Treatment of Macular Degeneration. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.5c01783

Vancouver

Nguyen VP, Jeong J, Zhe J, Zheng M, Lee J, Tran K, et al. Silicon Nanoneedle Patches for Painless, Sustained Treatment of Macular Degeneration. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.5c01783

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Van Phuc and Jeong, Jinheon and Zhe, Josh and Zheng, Mi and Lee, Junsang and Tran, Khoi and Wei, Zhuying and Lee, Chi Hwan and Paulus, Yannis M},
  title = {Silicon Nanoneedle Patches for Painless, Sustained Treatment of Macular Degeneration},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  doi = {10.1021/acsbiomaterials.5c01783}
}
Kostenlos starten →